Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve a) To consider and approve Standalone and Consolidated Audited Financial Results of the Company for the Quarter and year ended 31st March, 2025; b) To take on record the Standalone and Consolidated Audit Report by Auditors for the Audited Financial Results of the Company for the Quarter and year ended 31st March, 2025. c) To consider and approve other matter incidental thereto